In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether

British Journal of Clinical Pharmacology

Volumn 49, Issue 5, 2000, Pages 437-444

  Tanariya, Peerapan ^a,b,c   Tippawangkoso, Pongsri ^a   Karbwang, Juntra ^a   Na Bangchang, Kesara ^b   Wernsdorfer, Walther H ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF VIENNA   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Artemether; Artemisinin; Benflumetol; Drug response; Lumefantrine; Plasmodium falciparum

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; BENFLUMETOL; CHLOROQUINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; ARTEMISININS; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SESQUITERPENES;

EID: 0034106867     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2000.00176.x     Document Type: Article

References (28)

1. China Cooperative Research Group on Qinghaosu and its Derivatives as Antimalarials. The chemistry and synthesis of qinghaosu derivatives. J Tradit Chin Mcd 1982; 2: 9-16.
2. Karbwang J, Na Bangchang K, Thanavibul A, et al. Comparison of oral artemether and mefloquine in acute uncomplicated falciparum malaria. Lancet 1992; 340: 1245-1248.
3. Brewer TG, Peggins JO, Grate SJ, ct al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 1994; 88 (Suppl 1): 33-36.
4. World Health Organization Practical chemotherapy of malaria. IVHO Technical Report Series ATo 805, Geneva, WHO 1990.
5. Alin MH, Björkman A, Wemsdorfer WH. Synergism of benflumetol and artemether in Plasmodiuinfalcipaniin. AinJ Trop Med Hyg 1999; 61: 439-445.
6. Novartis. Meeting the challenge: CGP 56697, a novel antiinalarial combination. London, Current Medical Literature Ltd 1997.
7. von Seidlein L, Jaffar S, Pinder M, et al. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697. J Infect Dis 1997; 176: 1113-1116.
8. von Seidlein L, Bojang K, Jones P, et al. Randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am J Trop Med Hyg 1998; 58: 638-644.
9. Hatz C, Abdulla S, Mull R, et al. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Trop Med Intentât tilth 1998; 3: 498-504.
10. Jiao X, Liu GY, Shan CO, et al. Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria. Soutlicast Asian J Trop Med Publ Hlth 1997; 28: 476-481.
11. Van Vugt M, Brockman A, Gemperli B, et al. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antiinicrob Agents Chcmothcr 1998; 42: 135-139.
12. Looareesuwan S, Wilairatana P, Chokejindachai W, et al. A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodiuin falcipannn malaria in Thailand. Am J Trop Med Hyg 1999; 60: 238-243.
13. Vugt MV, Wilairatana P, Gemperli B, et al. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodiuin faldpamni malaria. Am J Trop Med Hyg 1999; 60: 936-942.
14. van Agtmael MA, Bouchaud O, Malvy D, et al. The comparative efficacy and tolerability of CGP 56697 (artemether and lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the tropics to The Netherlands and France, lut J Antiinicrob Agents 1999; 12: 159-169.
15. Ezzet F, Mull R, KarbwangJ. Population phamiacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients. BrJ Clin Phannacol 1998; 46: 553-561.
16. Richards WHG, Maples BK. Studies on Plasmodiuin falcipanim in continuous cultivation. I. The effect of chloroquine and pyriniethamine on parasite growth and viability. Ann Trop Med Parasitai 1979; 73: 99-108.
17. Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976; 193: 673-675.
18. Litchfield JT, Wilcoxon F. A simplified method for evaluating dose-effect experiments. J Phannacol Exp Tlier 1949; 96: 99-113.
19. Daniel WW. Biostatistics: a Foundation for Analysis in the Health Sciences 5th edn. 1991; John Wiley & Sons, New York.
20. Wemsdorfer WH, Landgraf B, Kilimali VA, et al. Activity of benflumetol and its enantiomers in fresh isolates of Plasmodium falciparum from East Africa. Acta Tropica 1998; 70: 9-15.
21. Wemsdorfer WH, Payne D. Drug sensitivity tests in malaria parasites. In Afalaria, Principles and Practice of Malariology eds Wemsdorfer WH, McGregor IA. Churchill Livingstone, Edinburgh, 1988: pp. 1765-1800.
22. Basco LK, Bickii J, Ringwald P. In vitro activity of lumefantrine (benflumetol) against clinical isolates of Plasmodium falcipanim in Yaounde, Cameroon. Antimcrob Agents Clienwtlicr 1998; 42: 2347-2351.
23. Pradines B, Tall A, Fusai T, et al. In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falcipanim in comparison with those of standard antimalarial drugs. Antiinicrob Agents Chcmothcr 1999; 43: 418-420.
24. White NJ. Preventing antimalarial drug resistance through combinations. Dnig Rests Update 1998; 1: 3-9.
25. White NJ, Nosten F, Looareesuwan S, et al. Averting a malaria disaster. Lancet 1999; 353: 1965-1967.
26. White NJ, van Vugt M, Ezzet F. Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin Phannacokinet 1999; 37: 105-125.
27. Wemsdorfer WH. Epidemiology of drug resistance in malaria. Ada Tropica 1994; 56: 143-156.
28. ter Kuile FO, Luxemburger F, Nosten F, et al. Predictors of mefloquine treatment failure: a prospective study in 1590 patients with uncomplicated falciparum malaria. Trans R Soc Trop Meet Hyg 1995; 89: 660-664.